Stay updated on CP-690,550 vs. Humira in RA Clinical Trial
Sign up to get notified when there's something new on the CP-690,550 vs. Humira in RA Clinical Trial page.

Latest updates to the CP-690,550 vs. Humira in RA Clinical Trial page
- Check6 days agoChange DetectedAdded related topic links for Rheumatoid arthritis and MedlinePlus Genetics to the page's related topics.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded Revision: v3.4.2 banner to the page. Removed Rheumatoid arthritis and related topics (MedlinePlus Genetics) and the Revision: v3.4.1 reference.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded the rheumatoid arthritis topic and a related topics section with MedlinePlus Genetics, and updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded an in-page glossary toggle and updated the Brno-Židenice, Czechia location entry. Minor editorial changes were made to QC status wording and the revision number (v3.4.0).SummaryDifference0.1%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4, indicating a minor page update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check56 days agoChange DetectedA new publication citation by Strand et al. was added to the Publications/From PubMed section. The cited BMJ Open article discusses sex differences in the efficacy and safety of tofacitinib in rheumatoid arthritis.SummaryDifference0.0%

Stay in the know with updates to CP-690,550 vs. Humira in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CP-690,550 vs. Humira in RA Clinical Trial page.